{"created":"2023-05-15T08:49:46.822091+00:00","id":511,"links":{},"metadata":{"_buckets":{"deposit":"f7aa63e5-2c31-45fb-996c-44536d554846"},"_deposit":{"created_by":3,"id":"511","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"511"},"status":"published"},"_oai":{"id":"oai:jumonji-u.repo.nii.ac.jp:00000511","sets":["25:85:86"]},"author_link":["641","1156"],"item_10007_contributor_5":{"attribute_name":"研究分担者","attribute_value_mlt":[{"contributorNames":[{"contributorName":"金髙, 有里"},{"contributorName":"キンタカ, ユリ","lang":"ja-Kana"}],"nameIdentifiers":[{"nameIdentifier":"1156","nameIdentifierScheme":"WEKO"}]}]},"item_10007_date_8":{"attribute_name":"報告年度","attribute_value_mlt":[{"subitem_date_issued_datetime":"2016","subitem_date_issued_type":"Issued"}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-04-30"}],"displaytype":"detail","filename":"16-43.pdf","filesize":[{"value":"297.7 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"16-43","url":"https://jumonji-u.repo.nii.ac.jp/record/511/files/16-43.pdf"},"version_id":"4b0678a5-02a1-41b6-9661-4226285636c8"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_researcher":{"attribute_name":"研究代表者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"山崎, 優子"}],"nameIdentifiers":[{"nameIdentifier":"641","nameIdentifierScheme":"WEKO"}]}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"research report","resourceuri":"http://purl.org/coar/resource_type/c_18ws"}]},"item_title":"食品添加物のリスク評価の考え方に基づくハーブサプリメント製品の安全性確保の提案 ―Cytochrome P450遺伝子発現を指標として―","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"食品添加物のリスク評価の考え方に基づくハーブサプリメント製品の安全性確保の提案 ―Cytochrome P450遺伝子発現を指標として―"}]},"item_type_id":"10007","owner":"3","path":["86"],"pubdate":{"attribute_name":"公開日","attribute_value":"2019-04-30"},"publish_date":"2019-04-30","publish_status":"0","recid":"511","relation_version_is_last":true,"title":["食品添加物のリスク評価の考え方に基づくハーブサプリメント製品の安全性確保の提案 ―Cytochrome P450遺伝子発現を指標として―"],"weko_creator_id":"3","weko_shared_id":3},"updated":"2023-05-15T09:05:32.659236+00:00"}